Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.pvr.2017.06.003
DC Field | Value | |
---|---|---|
dc.title | What works for human papillomavirus vaccine introduction in low and middle-income countries? | |
dc.contributor.author | Howard, N | |
dc.contributor.author | Gallagher, KE | |
dc.contributor.author | Mounier-Jack, S | |
dc.contributor.author | Burchett, HED | |
dc.contributor.author | Kabakama, S | |
dc.contributor.author | LaMontagne, DS | |
dc.contributor.author | Watson-Jones, D | |
dc.date.accessioned | 2021-11-02T04:37:24Z | |
dc.date.available | 2021-11-02T04:37:24Z | |
dc.date.issued | 2017-12-01 | |
dc.identifier.citation | Howard, N, Gallagher, KE, Mounier-Jack, S, Burchett, HED, Kabakama, S, LaMontagne, DS, Watson-Jones, D (2017-12-01). What works for human papillomavirus vaccine introduction in low and middle-income countries?. Papillomavirus Research 4 : 22-25. ScholarBank@NUS Repository. https://doi.org/10.1016/j.pvr.2017.06.003 | |
dc.identifier.issn | 24058521 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/205396 | |
dc.description.abstract | Since 2007, low and middle-income countries (LMICs) have gained experience delivering HPV vaccines through HPV vaccination pilots, demonstration projects and national programmes. This commentary summarises lessons from HPV vaccination experiences in 45 LMICs and what works for HPV vaccination introduction. Methods included a systematic literature review, unpublished document review, and key informant interviews. Data were extracted from 61 peer-reviewed articles, 11 conference abstracts, 188 technical reports, and 56 interviews, with quantitative data analysed descriptively and qualitative data analysed thematically. Key lessons are described under five themes of preparation, communications, delivery, coverage achievements, and sustainability. Lessons learnt were generally consistent across countries and projects and sufficient lessons have been learnt for countries to deliver HPV vaccine through phased national rollout rather than demonstration projects. However, challenges remain in securing the political will and financial resources necessary to implement successful national programmes. | |
dc.publisher | Elsevier BV | |
dc.source | Elements | |
dc.subject | Cervical cancer prevention | |
dc.subject | Demonstration projects | |
dc.subject | Human papillomavirus | |
dc.subject | Low and middle-income countries | |
dc.subject | Vaccination | |
dc.type | Article | |
dc.date.updated | 2021-10-30T09:44:02Z | |
dc.contributor.department | SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH | |
dc.description.doi | 10.1016/j.pvr.2017.06.003 | |
dc.description.sourcetitle | Papillomavirus Research | |
dc.description.volume | 4 | |
dc.description.page | 22-25 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
What works for human papillomavirus vaccine introduction in low and middle-income countries.pdf | Published version | 455.67 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.